| Jeanine Yamanaka, MD | |
|
850 S. Atlantic Blvd., 301, Monterey Park, CA 91754-4769 | |
| (626) 289-7699 | |
| Not Available |
| Full Name | Jeanine Yamanaka |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 850 S. Atlantic Blvd., Monterey Park, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972707677 | NPI | - | NPPES |
| GR0079700 | Medicaid | CA | |
| 00A686980 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A68698 (California) | Primary |
| Entity Name | Paul T Urrea M D M P H Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619074838 PECOS PAC ID: 9638130735 Enrollment ID: O20041021001057 |
News Archive
According to the World Health Organization, the two controversial studies that explain how scientists mutated the H5N1 bird flu virus into a form that could cause a deadly human pandemic will be published only after experts fully assess the risks.
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.
Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeanine Yamanaka, MD 850 S. Atlantic Blvd., 301, Monterey Park, CA 91754-4769 Ph: () - | Jeanine Yamanaka, MD 850 S. Atlantic Blvd., 301, Monterey Park, CA 91754-4769 Ph: (626) 289-7699 |
News Archive
According to the World Health Organization, the two controversial studies that explain how scientists mutated the H5N1 bird flu virus into a form that could cause a deadly human pandemic will be published only after experts fully assess the risks.
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.
Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.
› Verified 8 days ago
Dr. Cheraphat Lopansri, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 223 N Garfield Ave., #306, Monterey Park, CA 91754 Phone: 626-573-5005 Fax: 626-573-8650 | |
Maria Petrova Pesheva, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 S Atlantic Blvd Ste 301, Monterey Park, CA 91754 Phone: 626-289-7699 | |
Dr. Tin-cheu Wong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 420 N Garfield Ave Ste 208, Monterey Park, CA 91754 Phone: 626-572-3937 Fax: 626-571-8819 | |
Bach Lan Linda Vu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 511 E Garvey Ave, Suite 201, Monterey Park, CA 91755 Phone: 626-382-2020 Fax: 626-382-2015 | |
Calvin Eng, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 S Atlantic Blvd, Suite 301, Monterey Park, CA 91754 Phone: 626-289-8260 Fax: 626-289-4242 | |
Jennifer Shin-hue Huang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 S Atlantic Blvd Ste 301, Monterey Park, CA 91754 Phone: 626-289-8260 Fax: 626-289-4242 | |
Joseph T Fan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 500 N Garfield Ave Ste 209, Monterey Park, CA 91754 Phone: 626-288-2265 Fax: 626-288-3761 |